92 related articles for article (PubMed ID: 19236103)
1. Investigation of the effect of glycosylation on human prion protein by molecular dynamics.
Zhong L; Xie J
J Biomol Struct Dyn; 2009 Apr; 26(5):525-33. PubMed ID: 19236103
[TBL] [Abstract][Full Text] [Related]
2. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulation of dimeric and monomeric forms of human prion protein: insight into dynamics and properties.
Sekijima M; Motono C; Yamasaki S; Kaneko K; Akiyama Y
Biophys J; 2003 Aug; 85(2):1176-85. PubMed ID: 12885661
[TBL] [Abstract][Full Text] [Related]
4. Simulations of biomolecules: Characterization of the early steps in the pH-induced conformational conversion of the hamster, bovine and human forms of the prion protein.
Alonso DO; An C; Daggett V
Philos Trans A Math Phys Eng Sci; 2002 Jun; 360(1795):1165-78. PubMed ID: 12804272
[TBL] [Abstract][Full Text] [Related]
5. Rare large scale subdomain motions in prion protein can initiate aggregation.
Schwarzinger S; Horn AH; Ziegler J; Sticht H
J Biomol Struct Dyn; 2006 Jun; 23(6):581-90. PubMed ID: 16615804
[TBL] [Abstract][Full Text] [Related]
6. Effects of pH and aggregation in the human prion conversion into scrapie form: a study using molecular dynamics with excited normal modes.
Lima AN; de Oliveira RJ; Braz ASK; de Souza Costa MG; Perahia D; Scott LPB
Eur Biophys J; 2018 Jul; 47(5):583-590. PubMed ID: 29546436
[TBL] [Abstract][Full Text] [Related]
7. Dynamic simulation of the mouse prion protein.
Guilbert C; Ricard F; Smith JC
Biopolymers; 2000 Nov; 54(6):406-15. PubMed ID: 10951327
[TBL] [Abstract][Full Text] [Related]
8. Distinct effects of Cu2+-binding on oligomerization of human and rabbit prion proteins.
Lin K; Yu Z; Yu Y; Liao X; Huang P; Guo C; Lin D
Acta Biochim Biophys Sin (Shanghai); 2015 Oct; 47(10):842-50. PubMed ID: 26350098
[TBL] [Abstract][Full Text] [Related]
9. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
Surewicz WK; Jones EM; Apetri AC
Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
[TBL] [Abstract][Full Text] [Related]
10. The interaction of humic substances with the human prion protein fragment 90-231 affects its protease K resistance and cell internalization.
Corsaro A; Anselmi C; Polano M; Aceto A; Florio T; De Nobili M
J Biol Regul Homeost Agents; 2010; 24(1):27-39. PubMed ID: 20385069
[TBL] [Abstract][Full Text] [Related]
11. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
Yam AY; Gao CM; Wang X; Wu P; Peretz D
PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
[TBL] [Abstract][Full Text] [Related]
12. Altered prion protein glycosylation in the aging mouse brain.
Goh AX; Li C; Sy MS; Wong BS
J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
[TBL] [Abstract][Full Text] [Related]
13. Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein.
Thackray AM; Madec JY; Wong E; Morgan-Warren R; Brown DR; Baron T; Bujdoso R
Biochem J; 2003 Feb; 370(Pt 1):81-90. PubMed ID: 12429022
[TBL] [Abstract][Full Text] [Related]
14. Modeling a prion protein dimer: predictions for fibril formation.
Warwicker J
Biochem Biophys Res Commun; 2000 Nov; 278(3):646-52. PubMed ID: 11095963
[TBL] [Abstract][Full Text] [Related]
15. A mathematical analysis of the dynamics of prion proliferation.
Greer ML; Pujo-Menjouet L; Webb GF
J Theor Biol; 2006 Oct; 242(3):598-606. PubMed ID: 16753184
[TBL] [Abstract][Full Text] [Related]
16. Structural studies on the folded domain of the human prion protein bound to the Fab fragment of the antibody POM1.
Baral PK; Wieland B; Swayampakula M; Polymenidou M; Rahman MH; Kav NN; Aguzzi A; James MN
Acta Crystallogr D Biol Crystallogr; 2012 Nov; 68(Pt 11):1501-12. PubMed ID: 23090399
[TBL] [Abstract][Full Text] [Related]
17. Structural rearrangements at physiological pH: nuclear magnetic resonance insights from the V210I human prion protein mutant.
Biljan I; Ilc G; Giachin G; Plavec J; Legname G
Biochemistry; 2012 Sep; 51(38):7465-74. PubMed ID: 22947063
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics of mouse and Syrian hamster PrP: implications for activity.
Parchment OG; Essex JW
Proteins; 2000 Feb; 38(3):327-40. PubMed ID: 10713992
[TBL] [Abstract][Full Text] [Related]
19. Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance.
Touil F; Pratt S; Mutter R; Chen B
J Pharm Biomed Anal; 2006 Mar; 40(4):822-32. PubMed ID: 16242887
[TBL] [Abstract][Full Text] [Related]
20. Monitoring prion protein stability by NMR.
Julien O; Graether SP; Sykes BD
J Toxicol Environ Health A; 2009; 72(17-18):1069-74. PubMed ID: 19697241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
